National Medical Products Administration (NMPA)

Sycume becomes China’s first approved IGF-1R monoclonal antibody for thyroid eye disease, offering a new treatment option after…

The company expands its global footprint with regulatory approval from China’s NMPA, reinforcing its leadership in antihistamine…